Synthetic microbiome therapy eliminates intestinal infection in mice without using antibiotics
A synthetic microbiome therapy, tested on mice, protects against the severe symptoms of a difficult-to-treat and potentially fatal intestinal infection in humans: Clostridioides difficile. Although inspired by the idea of human faecal transplants, the new approach does not require faecal matter. Instead, it uses fewer, but more precise, bacterial strains. The study is published in the journal Cell Host & Microbe.